UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000044237 |
|---|---|
| Receipt number | R000050500 |
| Scientific Title | Cardiac Involvement of Coronavirus Disease 2019 Assessed by Cardiac Magnetic Resonance: A Meta-analysis |
| Date of disclosure of the study information | 2021/05/17 |
| Last modified on | 2023/11/29 09:43:36 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Cardiac Involvement of Coronavirus Disease 2019 Assessed by Cardiac Magnetic Resonance: A Meta-analysis
Acronym
Cardiac Involvement by COVID-19: A meta-analysis
Scientific Title
Cardiac Involvement of Coronavirus Disease 2019 Assessed by Cardiac Magnetic Resonance: A Meta-analysis
Scientific Title:Acronym
Cardiac Involvement by COVID-19: A meta-analysis
Region
| Japan |
Condition
Condition
COVID-19
Classification by specialty
| Medicine in general | Cardiology | Radiology |
| Emergency medicine | Intensive care medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
This study aimed to perform a meta-analysis of the prevalence of cardiac abnormalities detected by CMR in patients with COVID-19.
Basic objectives2
Others
Basic objectives -Others
LV and RV ejection fraction will be compared with those of control subjects.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Prevalence of cardiac involvement in patients with COVID-19 (LV or RV dysfunction, myocardial edema (T2WI, T2 mapping), non-ischemic myocardial injury (LGE, native T1 mapping)).
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
In the electronic search, we will systematically searched Pubmed, EMBASE, the Cochrane Central Register of Controlled Trials, and Web of Science Core Collection. Search formulas were presented as supplementary data.
Key exclusion criteria
Case report will be excluded from analysis.
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Shingo |
| Middle name | |
| Last name | Kato |
Organization
Yokohama City University Graduate School of Medicine
Division name
Department of Diagnostic Radiology
Zip code
236-0004
Address
3-9, Fukuura, Kanazawaku Yokohama
TEL
045-787-2696
sk513@yokohama-cu.ac.jp
Public contact
Name of contact person
| 1st name | Shingo |
| Middle name | |
| Last name | Kato |
Organization
Yokohama City University Graduate School of Medicine
Division name
Department of Diagnostic Radiology
Zip code
236-0004
Address
3-9, Fukuura, Kanazawaku Yokohama
TEL
045-787-2696
Homepage URL
sk513@yokohama-cu.ac.jp
Sponsor or person
Institute
Department of Diagnostic Radiology, Yokohama City University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Department of Diagnostic Radiology, Yokohama City University Graduate School of Medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
IRB of Yokohama City University
Address
3-9 Fukuura, Kanazawaku
Tel
045-787-2696
sk513@yokohama-cu.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 05 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2021 | Year | 05 | Month | 17 | Day |
Date of IRB
| 2021 | Year | 05 | Month | 17 | Day |
Anticipated trial start date
| 2021 | Year | 05 | Month | 17 | Day |
Last follow-up date
| 2021 | Year | 07 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
N/A
Management information
Registered date
| 2021 | Year | 05 | Month | 17 | Day |
Last modified on
| 2023 | Year | 11 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050500
